(Q39701844)

English

A randomized trial on the efficacy of methylphenidate and modafinil for improving cognitive functioning and symptoms in patients with a primary brain tumor

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

A randomized trial on the efficacy of methylphenidate and modafinil for improving cognitive functioning and symptoms in patients with a primary brain tumor (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

0 references

1 reference

based on heuristic

inferred from title

randomized experiment

1 reference

based on heuristic

inferred from title

author name string

K Gehring

1

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

S Y Patwardhan

2

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

R Collins

3

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

M D Groves

4

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

C J Etzel

5

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

C A Meyers

6

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

J S Wefel

7

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

publication date

2 October 2011

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Journal of Neuro-Oncology

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

107

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

165-174

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

randomized experiment

0 references

https://scigraph.springernature.com/pub.10.1007/s11060-011-0723-1

0 references

Cognitive deficits in adult patients with brain tumours

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0723-1

21 January 2018

Interventions for cognitive deficits in patients with a brain tumor: an update

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0723-1

21 January 2018

Clinically relevant doses of methylphenidate significantly occupy norepinephrine transporters in humans in vivo

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0723-1

21 January 2018

Methylphenidate for the treatment of Parkinson disease and other neurological disorders

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0723-1

21 January 2018

Use of methylphenidate in traumatic brain injury

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0723-1

21 January 2018

Modafinil and methylphenidate for neuroenhancement in healthy individuals: A systematic review

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0723-1

21 January 2018

Effects of modafinil on dopamine and dopamine transporters in the male human brain: clinical implications

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0723-1

21 January 2018

Cognitive enhancing effects of modafinil in healthy volunteers

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0723-1

21 January 2018

Effects of modafinil on working memory processes in humans

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0723-1

21 January 2018

Modafinil improves alertness, vigilance, and executive function during simulated night shifts

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0723-1

21 January 2018

Action of modafinil--increased motivation via the dopamine transporter inhibition and D1 receptors?

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0723-1

21 January 2018

Modafinil shifts human locus coeruleus to low-tonic, high-phasic activity during functional MRI.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0723-1

21 January 2018

Modafinil for the treatment of multiple sclerosis-related fatigue

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0723-1

21 January 2018

Efficacy and safety of modafinil in the treatment of cancer-related fatigue

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0723-1

21 January 2018

Methylphenidate in the treatment of neurobehavioral slowing associated with cancer and cancer treatment

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0723-1

21 January 2018

Methylphenidate therapy improves cognition, mood, and function of brain tumor patients.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0723-1

21 January 2018

A phase III, double-blind, placebo-controlled prospective randomized clinical trial of d-threo-methylphenidate HCl in brain tumor patients receiving radiation therapy.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0723-1

21 January 2018

Psychostimulants for the management of cancer-related fatigue: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0723-1

21 January 2018

The use of psychostimulants in cancer patients.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0723-1

21 January 2018

Methylphenidate side effects in advanced cancer: a retrospective analysis

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0723-1

21 January 2018

Neuropsychological effects of methylphenidate in patients receiving a continuous infusion of narcotics for cancer pain

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0723-1

21 January 2018

A randomised, placebo-controlled, double-blind trial of the effects of d-methylphenidate on fatigue and cognitive dysfunction in women undergoing adjuvant chemotherapy for breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0723-1

21 January 2018

The effect of modafinil on cognitive function in breast cancer survivors

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0723-1

21 January 2018

Modafinil for attentional and psychomotor dysfunction in advanced cancer: a double-blind, randomised, cross-over trial

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0723-1

21 January 2018

A pilot study evaluating the safety and efficacy of modafinal for cancer-related fatigue

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0723-1

21 January 2018

Practice effects during repeated administrations of memory tests with and without alternate forms.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0723-1

21 January 2018

Visuospatial learning: Ruff Light Trail Learning Test

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0723-1

21 January 2018

Normative data for determining significance of test-retest differences on eight common neuropsychological instruments.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0723-1

21 January 2018

Cognitive effects of modafinil in student volunteers may depend on IQ.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0723-1

21 January 2018

Effects of modafinil and methylphenidate on visual attention capacity: a TVA-based study.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0723-1

21 January 2018

Psychostimulants as cognitive enhancers: the prefrontal cortex, catecholamines, and attention-deficit/hyperactivity disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/21964738

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Methylphenidate hydrochloride improves cognitive function in patients with advanced cancer and hypoactive delirium: a prospective clinical study

1 reference

https://pubmed.ncbi.nlm.nih.gov/21964738

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Methylphenidate treatment of patients with head and neck cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21964738

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mechanism of action of methylphenidate: insights from PET imaging studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/21964738

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation

1 reference

https://pubmed.ncbi.nlm.nih.gov/21964738

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11060-011-0723-1

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39701844&oldid=2088996491"